Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-032331
Filing Date
2021-05-13
Accepted
2021-05-13 16:18:47
Documents
1
Period of Report
2021-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3905
  Complete submission text file 0001209191-21-032331.txt   5529
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Joseph Donald (Reporting) CIK: 0001319460 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 21919915